A new breath test could revolutionize breast cancer screening if approved following a series of North American studies.
Moncton-based company Breathe BioMedical has developed a test that can detect signs of breast cancer by analyzing breath samples in women of all breast density types.
“It’s very exciting to see a new technology that potentially could be able to reach the masses, the capacity wouldn’t be an issue, and that we’d be able to find cancer early,” says Jennie Dale, founder and executive director of national non-profit Dense Breasts Canada.
Mammography is currently considered the gold standard screening tool, Dale says, but it is far…
Read the full article at GLOBALNEWS.CA
